Clinical applications of in vivo magnetic resonance spectroscopy in oncology.

Clinical applications of in vivo magnetic resonance spectroscopy in oncology.
Phys Med Biol. 2018 Oct 26;63(21):21TR02
Authors: Payne GS
Abstract
Magnetic resonance spectroscopy (MRS) can be performed in vivo using commercial MRI systems to obtain biochemical information about tissues and cancers. Applications in brain, prostate and breast aid lesion detection and characterisation (differential diagnosis), treatment planning and response assessment. Multi-centre clinical trials have been performed in all these tissues. Single centre studies have been performed in many other tissues including cervix, uterus, musculoskeletal and liver. While generally MRS is used to study endogenous metabolites it has also been used in drug studies, for example those that include 19F as part of their structure. Recently the hyperpolarisation of compounds enriched with 13C such as [1-13C] pyruvate has been demonstrated in animal models and now in preliminary clinical studies, permitting the monitoring of biochemical processes with unprecedented sensitivity. This review briefly introduces the underlying methods and then discusses the current status of these applications.
PMID: 30362466 [PubMed - in process]

Source: Physics in Medicine and Biology - October 26, 2018 Category: Physics Authors: Payne GS Tags: Phys Med Biol Source Type: research